MedCap AB (publ)
STO:MCAP

Watchlist Manager
MedCap AB (publ) Logo
MedCap AB (publ)
STO:MCAP
Watchlist
Price: 541 SEK -4.25% Market Closed
Market Cap: 8B SEK
Have any thoughts about
MedCap AB (publ)?
Write Note

MedCap AB (publ)
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MedCap AB (publ)
Cost of Revenue Peer Comparison

Comparables:
ALIF B
BICO
BIOT
G
GENO
M
MAGLE

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
MedCap AB (publ)
STO:MCAP
Cost of Revenue
-kr954.9m
CAGR 3-Years
-32%
CAGR 5-Years
-24%
CAGR 10-Years
-4%
AddLife AB
STO:ALIF B
Cost of Revenue
-kr6B
CAGR 3-Years
-21%
CAGR 5-Years
-31%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Cost of Revenue
-kr1.1B
CAGR 3-Years
-75%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Cost of Revenue
-kr794m
CAGR 3-Years
-19%
CAGR 5-Years
-15%
CAGR 10-Years
-14%
G
Genovis AB
STO:GENO
Cost of Revenue
-kr45.2m
CAGR 3-Years
-43%
CAGR 5-Years
-64%
CAGR 10-Years
-12%
M
Magle Chemoswed Holding AB
STO:MAGLE
Cost of Revenue
-kr16.5m
CAGR 3-Years
18%
CAGR 5-Years
-6%
CAGR 10-Years
N/A

See Also

What is MedCap AB (publ)'s Cost of Revenue?
Cost of Revenue
-954.9m SEK

Based on the financial report for Sep 30, 2024, MedCap AB (publ)'s Cost of Revenue amounts to -954.9m SEK.

What is MedCap AB (publ)'s Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-4%

Over the last year, the Cost of Revenue growth was -24%. The average annual Cost of Revenue growth rates for MedCap AB (publ) have been -32% over the past three years , -24% over the past five years , and -4% over the past ten years .

Back to Top